Chemistry: analytical and immunological testing – Biospecific ligand binding assay – Utilizing isolate of tissue or organ as binding agent
Reexamination Certificate
2005-04-15
2008-11-25
Weber, Jon P (Department: 1657)
Chemistry: analytical and immunological testing
Biospecific ligand binding assay
Utilizing isolate of tissue or organ as binding agent
C436S053000
Reexamination Certificate
active
07456027
ABSTRACT:
The present invention identifies biomarkers that are diagnostic of nerve cell injury, organ injury, and/or neuronal disorders. Detection of different biomarkers of the invention are also diagnostic of the degree of severity of nerve injury, the cell(s) involved in the injury, and the subcellular localization of the injury.
REFERENCES:
patent: 5118606 (1992-06-01), Lynch et al.
patent: 6048703 (2000-04-01), Siman et al.
patent: 6589746 (2003-07-01), Zelman
patent: 2003/0040660 (2003-02-01), Jackowski et al.
patent: 2004/0241762 (2004-12-01), Shaw et al.
patent: 2005/0202508 (2005-09-01), Pasinetti
patent: 2005/0260654 (2005-11-01), Hayes et al.
patent: 2006/0246489 (2006-11-01), Svetlov et al.
patent: 2007/0003982 (2007-01-01), Hayes et al.
patent: WO 95/26506 (1995-10-01), None
Estrov et al. Caspase 2 and Caspase 3 Protein Levels as Predictors of Survival in Acute Myelogenous Leukemia; Blood, vol. 92, No. 9 (1998) pp. 3090-3097.
Woolf et al. Hippocampal Microtubule-Associated Protein-2 Alterations With Contextual Memory; Brain Research, vol. 821 (1999) pp. 241-249.
Li et al. Neuronal Damage and Plasticity Identified by Microtubule-Associated Protein 2, Growth-Associated Protein 43, and Cyclin D1 Immunoreactivity After Focal Cerebral Ishemia in Rats; Stroke, vol. 29 (1998) pp. 1972-1981.
Malmendal et al. Nascent Structure in the Kinase Anchoring Domain of Microtubule-Associated Protein 2; Biochemical and Biophysical Research Communications, vol. 301 (2003) pp. 136-142.
Posmantur et al. Neurofilament 68 and Neurofilament 200 Protein Levels Decrease After Traumatic Brain Injury; Journal of Neurotrauma, vol. 11, No. 5 (1994) pp. 533-545.□□.
Nam et al. Nanoparticle-Based Bio-Bar Codes for the Ultrasensitive Detection of Proteins; Science, vol. 301 (2003) pp. 1884-1886.
Liu et al. Extensive Myelin Basic Protein Degradation in the Rat Brain After Traumatic Brain Injury; Journal of Neurochemistry, vol. 87, Supplement 1 (2003) pp. 146.
Blasko et al. Experimental Traumatic Brain Injury in Rats Stimulates the Expression, Production and Activity of Alzheimer's Disease Beta-Secretase (BACE-1); Journal of Neural Transmission, vol. 111 (2004) pp. 523-536.
Zemlan et al. C-Tau Biomarker of Neuronal Damage in Severe Brain Injured Patients: Association With Elevated Intracranial Pressure and Clinical Outcome; Brain Research, vol. 947 (2002) pp. 131-139.
Borghi, R. et al. “Full length alpha-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects”, 2000, Neuroscience Letters, 287:65-67.
Dambinova, S. et al. “The presence of autoantibodies to N-terminus domain of GluR1 subunit of AMPA receptor in the blood serum of patients with epilepsy”, 1997, Journal of Neurological Sciences, 152:93-97.
Dambinova, S. et al. “Blood Test Detecting Autoantibodies to N-Methyl-D-aspartate Neuroreceptors for Evaluation of Patients with Transient Ischemic Attack and Stroke”, 2003, Clinical Chemistry, 49(10):1752-1762.
Jakowec, M. et al. “The native form of alpha-synuclein is not found in the cerebrospinal fluid of patients with Parkinson's disease or normal controls”, 1998, Neuroscience Letters, 253:13-16.
Posmantur, R. et al. “A calpain inhibitor attenuates cortical cytoskeletal protein loss after experimental traumatic brain injury in the rat”, 1997, Neuroscience, 77(3):875-888.
Pike, B. et al. “Accumulation of non-erythroid alpha II-spectrin and calpain-cleaved alpha II-spectrin breakdown products in cerebrospinal fluid after traumatic brain injury in rats”, 2001, Journal of Neurochemistry, 78:1297-1306.
Rosengren, L. et al. “Patients with Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases Have Increased Levels of Neurofilament Protein in CSF”, 1996, Journal of Neurochemistry, 67(5):2013-2018.
Zemlan, F. et al. “Quantification of Axonal Damage in Traumatic Brain Injury: Affinity Purification and Characterization of Cerebrospinal Fluid Tau Proteins”, 1999, Jounal of Neurochemistry, 72(2):741-750.
Sjogren, M. et al. “Neurofilament Protein in Cerebrospinal Fluid: A Marker of White Matter Changes”, 2001, Journal of Neuroscience Research, 66:510-516.
Shea, T. et al. “Calcium Influx into Human Neuroblastoma Cells Induces ALZ-50 Immunoreactivity: Involvement of Calpain-Mediated Hydrolysis of Protein Kinase C”, 1996, Journal of Neurochemistry, 66(4):1539-1549.
Denning, M. et al. “Protein Kinase C delta is Activated by Capase-dependent Proteolysis during Ultraviolet Radiation-induced Apoptosis of Human Keratinocytes”, 1998, The Journal of Biological Chemistry, 273(45)29995-30002.
Koriyama, H. et al. “Proteolytic Activation of Protein Kinase C delta and epsilon by Capase-3 in U937 Cells During Chemotherapeutic Agent-Induced Apoptosis”, 1999, Cell Signal, 11(11):831-838.
Schwab, BL et al. “Cleavage of plasma membrane calcium pumps by caspases: a link between apoptosis and necrosis”, 2002, Cell Death and Differentiation, 9:818-831.
Hajimohammadreza, I. et al. “A Specific Inhibitor of Calcium-Calmodulin-Dependent Protein Kinase-II Provides Neuroprotection Against NMDA- and Hypoxia/Hypoglycemia-Induced Cell Death”, 1995, The Journal of Neuroscience, 15(5)4093-4101.
Hajimohammadreza, I.et al. “Neuronal Nitric Oxide Synthase and Calmodulin-Dependent Protein Kinase II alpha Undergo Neurotoxin-Induced Proteolysis”, 1997, Journal of Neuorchemistry, 69(3):1006-1013.
Toyota, H. et al. “Calpain-induced Bax-clevage product is a more potent inducer of cell death than wild-type Bax”, 2003, Cancer Letters, 189:221-230.
McGinnist, K. et al. “Calcium/Calmodulin-dependent Protein Kinase IV Is Cleaved by Caspase-3 and Calpain in SH-SY5Y Human Neuroblastoma Cells Undergoing Apoptosis”, 1998, The Journal of Biological Chemistry, 273(32):19993-20000.
Cao, X. et al. “Cleavage of Bax to p18 Bax accelerates stress-induced apoptosis, and a cathespin-like protease may rapidly degrade p18 Bax”, 2003, Blood, 102(7):2605-2614.
Shigeta K. et al. “Fragmentation of a 70000-dalton calpastatin molecule upon its complex formation with calpain”, 1984, Biochem. Int., 9(3):327-33.
Mukerjee, N. et al. “Caspase-Mediated Calcineurin Activation Contributes to IL-2 Release during T Cell Activation”, 2001, Biochemical and Biophysical Research Communications, 285(5):1192-1199.
Estrov, et al, “Caspase 2 and Caspase 3 Protein Levels as Predictors of Survival in Acute Myelogenous Leukemia”,Blood, Nov. 1, 1998, pp. 3090-3097, vol. 92, No. 9.
Pettigrew, L. Creed, et al., “Microtubular Proteolysis in Focal Cerebral Ischemia”,Journal of Cerebral Blood Flow&Metabolism, 1996, pp. 1189-1202, vol. 16.
Hayes Ronald
Liu Ming Chen
Oli Monika
Wang Kevin Ka-Wang
Banyan Biomarkers, Inc.
Martin Paul C.
Saliwanchik Lloyd & Saliwanchik
University of Florida Research Foundation Inc.
Weber Jon P
LandOfFree
Proteolytic biomarkers for traumatic injury to the nervous... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Proteolytic biomarkers for traumatic injury to the nervous..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Proteolytic biomarkers for traumatic injury to the nervous... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4046361